Non-alcoholic Fatty Liver Disease Concept

subject area of

• AMPK as a Therapeutic Target for Treating Metabolic Diseases  Academic Article
• Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models  Academic Article
• Adolescent Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Young Adulthood  Academic Article
• Adverse metabolic effects of a hypercaloric, high-fat diet in rodents precede observable changes in body weight  Academic Article
• Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys  Academic Article
• Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats  Academic Article
• Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes  Academic Article
• Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients  Academic Article
• Berberine Prevents Disease Progression of Nonalcoholic Steatohepatitis through Modulating Multiple Pathways  Academic Article
• Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study  Academic Article
• Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis  Academic Article
• Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease  Academic Article
• Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis  Academic Article
• Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials  Academic Article
• Exposure to high fructose corn syrup during adolescence in the mouse alters hepatic metabolism and the microbiome in a sex‐specific manner  Academic Article
• Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation  Academic Article
• Fluoxetine-induced hepatic lipid accumulation is linked to elevated serotonin production  Academic Article
• Fluoxetine‐induced hepatic lipid accumulation is mediated by prostaglandin endoperoxide synthase 1 and is linked to elevated 15‐deoxy‐Δ ^12,14 PGJ ₂  Academic Article
• Fructose, pregnancy and later life impacts  Academic Article
• Fructose-Containing Sugars, Blood Pressure, and Cardiometabolic Risk: A Critical Review  Academic Article
• GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury  Academic Article
• GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease  Academic Article
• Guidelines of prevention and treatment of nonalcoholic fatty liver disease (2018, China)  Academic Article
• High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage Pathway  Academic Article
• Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes  Academic Article
• Increased incidence of non-alcoholic fatty liver disease in male rat offspring exposed to fluoxetine during fetal and neonatal life involves the NLRP3 inflammasome and augmented de novo hepatic lipogenesis  Academic Article
• Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis  Academic Article
• Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia  Academic Article
• Lower brown adipose tissue activity is associated with non-alcoholic fatty liver disease but not changes in the gut microbiota  Academic Article
• Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring  Academic Article
• Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure  Academic Article
• NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice  Academic Article
• Nontargeted Serum Lipid Profiling of Nonalcoholic Steatohepatitis by Multisegment Injection–Nonaqueous Capillary Electrophoresis–Mass Spectrometry: A Multiplexed Separation Platform for Resolving Ionic Lipids  Academic Article
• Offspring of Mothers Fed a High Fat Diet Display Hepatic Cell Cycle Inhibition and Associated Changes in Gene Expression and DNA Methylation  Academic Article
• Overstated Associations Between Fructose and Nonalcoholic Fatty Liver Disease  Academic Article
• Reply  Academic Article
• Roux-en-Y Gastric Bypass Versus Adjustable Gastric Banding to Reduce Nonalcoholic Fatty Liver Disease  Academic Article
• Treatment of nonalcoholic fatty liver disease: role of AMPK  Academic Article
• Unique microbial-derived volatile organic compounds in portal venous circulation in murine non-alcoholic fatty liver disease  Academic Article
• Validation of noninvasive biomarkers (FibroTest, SteatoTest, and NashTest) for prediction of liver injury in patients with morbid obesity  Academic Article
• Western diet consumption through early life induces microvesicular hepatic steatosis in association with an altered metabolome in low birth weight Guinea pigs  Academic Article
• [Comparative study of clinicopathological features, and risk factors of advanced fibrosis between genders with non-alcoholic fatty liver disease].  Academic Article